Caspase-independent programmed cell death with necrotic morphology

Cell death is generally classified into two large categories: apoptosis represents active, programmed cell death, while necrosis represents passive cell death without underlying regulatory mechanisms. Recent progress revealed that caspases, a family of cysteine proteases, play a central role in the regulation of apoptosis. Unexpectedly, however, caspase inhibition occasionally turns the morphology of programmed cell death from apoptotic into necrotic without inhibiting death itself. In this article, we review different models of caspase-independent programmed cell death showing necrotic-like morphology, including our Ras-mediated caspase-independent cell death. Based on these findings, we suggest the existence of a necrotic-like cell death regulated by cellular intrinsic death programs distinct from that of apoptosis. Even though type 2 physiological cell death, or autophagic degeneration, has been recognized as a necrotic-like programmed cell death for a long time, the underlying molecular mechanisms have not been identified despite its physiological significance. This has been in part due to the previous absence of adequate caspase-independent cellular models to study, recent efforts may now help to elucidate these mechanisms.

[1]  J. Kaplan,et al.  Gαs-Induced Neurodegeneration inCaenorhabditis elegans , 1998, The Journal of Neuroscience.

[2]  H. Horvitz,et al.  Genetic control of programmed cell death in the nematode C. elegans , 1986, Cell.

[3]  D. Fisher Apoptosis in cancer therapy: Crossing the threshold , 1994, Cell.

[4]  Y. Tsujimoto,et al.  Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions. , 1996, Oncogene.

[5]  W. Bursch,et al.  Cell death: programmed, apoptosis, necrosis, or other? , 1995, Cell death and differentiation.

[6]  Guy S. Salvesen,et al.  X-linked IAP is a direct inhibitor of cell-death proteases , 1997, Nature.

[7]  R. Plasterk,et al.  G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS‐1 induces neuronal degeneration , 1998, The EMBO journal.

[8]  G. Cohen,et al.  Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. , 1998, Journal of immunology.

[9]  Y. Agid,et al.  Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.

[10]  Junying Yuan,et al.  Human ICE/CED-3 Protease Nomenclature , 1996, Cell.

[11]  L. Schwartz,et al.  Do all programmed cell deaths occur via apoptosis? , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Xiaodong Wang,et al.  Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.

[13]  A. Watson,et al.  Commitment to cell death measured by loss of clonogenicity is separable from the appearance of apoptotic markers , 1998, Cell Death and Differentiation.

[14]  C. Der,et al.  Increasing Complexity of the Ras Signaling Pathway* , 1998, The Journal of Biological Chemistry.

[15]  D. Hall,et al.  Neuropathology of Degenerative Cell Death in Caenorhabditis elegans , 1997, The Journal of Neuroscience.

[16]  M. Chalfie,et al.  The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans , 1990, Nature.

[17]  Shai Shaham,et al.  The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme , 1993, Cell.

[18]  M. Koken,et al.  PML induces a novel caspase-independent death process , 1998, Nature Genetics.

[19]  Y. Tsujimoto Apoptosis and necrosis: Intracellular ATP level as a determinant for cell death modes , 1997, Cell Death and Differentiation.

[20]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[21]  J. Berzofsky,et al.  Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. , 1997, Immunity.

[22]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[23]  I. Tannock,et al.  Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1beta-converting enzyme inhibition. , 1998, Cancer research.

[24]  W. Fiers,et al.  Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death Pathways , 1998, The Journal of experimental medicine.

[25]  I. Tannock,et al.  Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a possible mechanism of tumour selective therapy. , 1993, British Journal of Cancer.

[26]  H. Horvitz,et al.  Mechanisms and functions of cell death. , 1991, Annual review of cell biology.

[27]  M. Raff,et al.  Programmed Cell Death in Animal Development , 1997, Cell.

[28]  D. Bredesen,et al.  Expression of bcl‐2 inhibits necrotic neural cell death , 1995, Journal of neuroscience research.

[29]  Jinhe Li,et al.  Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.

[30]  G. Kroemer,et al.  The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death , 1997, Oncogene.

[31]  S. Nagata,et al.  Caspase-independent Cell Killing by Fas-associated Protein with Death Domain , 1998, The Journal of cell biology.

[32]  K. Schulze-Osthoff,et al.  Divergent signalling via APO‐1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. , 1994, The EMBO journal.

[33]  S. Korsmeyer,et al.  Bax Deletion Further Orders the Cell Death Pathway in Cerebellar Granule Cells and Suggests a Caspase-independent Pathway to Cell Death , 1997, The Journal of cell biology.

[34]  M. Lavin,et al.  The ICE family of cysteine proteases as effectors of cell death. , 1996, Cell death and differentiation.

[35]  J. Kaplan,et al.  G alphas-induced neurodegeneration in Caenorhabditis elegans. , 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  W. Fiers,et al.  Inhibition of Caspases Increases the Sensitivity of L929 Cells to Necrosis Mediated by Tumor Necrosis Factor , 1998, The Journal of experimental medicine.

[37]  Seamus J. Martin,et al.  Anti-apoptotic oncogenes prevent caspase-dependent and independent commitment for cell death , 1998, Cell Death and Differentiation.

[38]  H. Horvitz,et al.  C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2 , 1994, Cell.

[39]  J. L. Bos,et al.  ras oncogenes in human cancer: a review. , 1989, Cancer research.

[40]  M. Sohrmann,et al.  An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. , 1997, Genes & development.

[41]  M. Barinaga Is Apoptosis Key in Alzheimer's Disease? , 1998, Science.

[42]  S. Yokoyama,et al.  Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cells , 1999, Oncogene.

[43]  Junying Yuan,et al.  Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3 , 1993, Cell.

[44]  M. Chalfie,et al.  The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration , 1991, Nature.

[45]  R E Burke,et al.  Apoptosis in neurodegenerative disorders. , 1997, Current opinion in neurology.

[46]  G. Evan,et al.  Inhibition of Ced-3/ICE-related Proteases Does Not Prevent Cell Death Induced by Oncogenes, DNA Damage, or the Bcl-2 Homologue Bak , 1997, The Journal of cell biology.

[47]  H. Merker,et al.  The morphology of various types of cell death in prenatal tissues. , 1973, Teratology.

[48]  R. Nixon,et al.  Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease , 1994, Brain Research.

[49]  M. Hung,et al.  Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis , 1998, Oncogene.

[50]  L. M. Schwartz The faces of death. , 1995, Cell death and differentiation.

[51]  L. Benítez-Bribiesca [Apoptosis in the pathogenesis and treatment of disease]. , 1995, Gaceta medica de Mexico.

[52]  J. Xiang,et al.  BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  M. Driscoll Cell Death in C. elegans: Molecular insights into Mechanisms Conserved Between Nematodes and Mammals , 1996, Brain pathology.

[54]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[55]  I. Tannock,et al.  The chronic administration of drugs that inhibit the regulation of intracellular pH: in vitro and anti-tumour effects. , 1996, British Journal of Cancer.

[56]  G. Gores,et al.  Selective induction of apoptosis in Hep 3B cells by topoisomerase I inhibitors: evidence for a protease-dependent pathway that does not activate cysteine protease P32. , 1996, The Journal of clinical investigation.

[57]  Gwyn T. Williams Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[58]  K. Noguchi,et al.  Caspase-dependent apoptosis of COS-7 cells induced by Bax overexpression: differential effects of Bcl-2 and Bcl-xL on Bax-induced caspase activation and apoptosis , 1997, Oncogene.

[59]  Martin Chalfie,et al.  Gene interactions affecting mechanosensory transduction in Caenorhabditis elegans , 1994, Nature.

[60]  P. Branton,et al.  E4orf4, a Novel Adenovirus Death Factor That Induces p53-independent Apoptosis by a Pathway That Is Not Inhibited by zVAD-fmk , 1998, The Journal of cell biology.